Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore

被引:0
|
作者
Hua JS
Bow H
Zheng PY
Khay-Guan Y
机构
[1] Department of Medicine Faculty of Medicine,National University of Singapore,5,Science Drive 2,Singapore 117597,Republic of Singapore
[2] Department of Microbiology Faculty of Medicine,National University of Singapore,5,Science Drive 2,Singapore 117597,Republic of Singapore
关键词
Subject headings; Helicobacter pylori; triple therapy; metronidazole; clarithromycin;
D O I
暂无
中图分类号
R573 [胃疾病];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTIONEradication of Helicobacter pylori,a bacteriumresiding in stomach and causing peptic ulcer disease,can be achieved by using combination therapiesconsisting of one or two antibiotics with a protonpump inhibitor (PPI).The major antibiotics widelyused in the regimens to eradicate H.pylori aremetronidazole and clarithromycin.However,resistance to these antibiotics by H.pylori affects
引用
收藏
页码:119 / 121
页数:3
相关论文
共 50 条
  • [1] Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore
    Hua, JS
    Bow, H
    Zheng, PY
    Khay-Guan, Y
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (01) : 119 - 121
  • [2] Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands
    vanZwet, AA
    deBoer, WA
    Schneeberger, PM
    Weel, J
    Jansz, AR
    Thijs, JC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (11) : 861 - 864
  • [3] Primary metronidazole and clarithromycin resistance for Helicobacter pylori in the US
    Osato, MS
    Reddy, R
    Reddy, SG
    Penland, RL
    Graham, DY
    Malath, HM
    GASTROENTEROLOGY, 2000, 118 (04) : A500 - A500
  • [4] Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil
    Magalhaes, PP
    Queiroz, DMD
    Barbosa, DVC
    Rocha, GA
    Mendes, EN
    Santos, A
    Corrêa, PRV
    Rocha, AMC
    Teixeira, LM
    de Oliveira, CA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 2021 - 2023
  • [5] Metronidazole and clarithromycin resistance in Helicobacter pylori
    Powell, K
    Kent, R
    Baldwin, L
    Bolton, G
    Williams, S
    GUT, 1999, 44 : A3 - A3
  • [6] Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population
    Koivisto, TT
    Rautelin, HI
    Voutilainen, ME
    Niemelä, SE
    Heikkinen, M
    Sipponen, PI
    Färkkilä, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (09) : 1009 - 1017
  • [7] Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon
    Sharara, AI
    Chedid, M
    Araj, GF
    Barada, KA
    Mourad, FH
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (02) : 155 - 158
  • [8] Prevalence of Helicobacter pylori metronidazole and clarithromycin resistance in Finland:: Associated factors
    Koivisto, TT
    Färkkilä, MA
    Niemela, SI
    Rautelin, HI
    Pikkarainen, PH
    Sipponen, PI
    GASTROENTEROLOGY, 2002, 122 (04) : A9 - A9
  • [9] Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland
    O'Connor, Anthony
    Taneike, Ikue
    Nami, Abdurrazag
    Fitzgerald, Niamh
    Murphy, Philip
    Ryan, Barbara
    O'Connor, Humphrey
    Qasim, Asghar
    Breslin, Niall
    O'Morain, Colm
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (09) : 1123 - 1127
  • [10] Primary and combined resistance in Helicobacter pylori to metronidazole, clarithromycin, ciprofloxacin and tetracycline
    Boyanova, L
    Stancheva, I
    Spassova, Z
    Koumanova, R
    Dotcheva, J
    Mitov, I
    GUT, 1999, 45 : A14 - A14